These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29040287)

  • 61. Comparative genomic analysis shows that avian pathogenic Escherichia coli isolate IMT5155 (O2:K1:H5; ST complex 95, ST140) shares close relationship with ST95 APEC O1:K1 and human ExPEC O18:K1 strains.
    Zhu Ge X; Jiang J; Pan Z; Hu L; Wang S; Wang H; Leung FC; Dai J; Fan H
    PLoS One; 2014; 9(11):e112048. PubMed ID: 25397580
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of Colistin and Bacteriocins Combinations on the In Vitro Growth of Escherichia coli Strains from Swine Origin.
    Al Atya AK; Abriouel H; Kempf I; Jouy E; Auclair E; Vachée A; Drider D
    Probiotics Antimicrob Proteins; 2016 Dec; 8(4):183-190. PubMed ID: 27557837
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multidrug-Resistant Escherichia coli in Bovine Animals, Europe.
    Brennan E; Martins M; McCusker MP; Wang J; Alves BM; Hurley D; El Garch F; Woehrlé F; Miossec C; McGrath L; Srikumar S; Wall P; Fanning S
    Emerg Infect Dis; 2016 Sep; 22(9):1650-2. PubMed ID: 27533105
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
    BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay.
    Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL
    BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MCR-1 Confers Cross-Resistance to Bacitracin, a Widely Used In-Feed Antibiotic.
    Xu F; Zeng X; Hinenoya A; Lin J
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30185515
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
    Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Virulence and antimicrobial resistance determinants of verotoxigenic Escherichia coli (VTEC) and of multidrug-resistant E. coli from foods of animal origin illegally imported to the EU by flight passengers.
    Nagy B; Szmolka A; Smole Možina S; Kovač J; Strauss A; Schlager S; Beutlich J; Appel B; Lušicky M; Aprikian P; Pászti J; Tóth I; Kugler R; Wagner M
    Int J Food Microbiol; 2015 Sep; 209():52-9. PubMed ID: 26148965
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae.
    Maalej SM; Meziou MR; Rhimi FM; Hammami A
    Lett Appl Microbiol; 2011 Nov; 53(5):546-51. PubMed ID: 21895730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs.
    Zhu W; Wang Y; Cao W; Cao S; Zhang J
    J Infect Public Health; 2018; 11(6):856-860. PubMed ID: 30057349
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of deferoxamine on intrinsic colistin resistance of
    Erinmez M; Zer Y
    Exp Ther Med; 2023 Sep; 26(3):459. PubMed ID: 37614438
    [No Abstract]   [Full Text] [Related]  

  • 76. The synergistic antibacterial activity and mechanism of colistin-oxethazaine combination against gram-negative pathogens.
    Li J; Han N; Li Y; Zhao F; Xiong W; Zeng Z
    Front Pharmacol; 2024; 15():1363441. PubMed ID: 38576480
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antimicrobial action of carbon monoxide-releasing compounds.
    Nobre LS; Seixas JD; Romão CC; Saraiva LM
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4303-7. PubMed ID: 17923486
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era.
    Wareham LK; Poole RK; Tinajero-Trejo M
    J Biol Chem; 2015 Jul; 290(31):18999-9007. PubMed ID: 26055702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel Antibacterials: Alternatives to Traditional Antibiotics.
    Betts JW; Hornsey M; La Ragione RM
    Adv Microb Physiol; 2018; 73():123-169. PubMed ID: 30262108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytological aspects of antimicrobial antibiosis. I. Cytological changes associated with the exposure of Escherichia coli to colistin sulfate.
    Chapman GB
    J Bacteriol; 1962 Jul; 84(1):169-79. PubMed ID: 13878175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.